Overview

Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery

Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to identify the "most simple non-inferior of three different methods", placebo, laparoscopic assisted transverse abdominal plane block (L-TAP) and ultrasound guided TAP block (US-TAP), using postoperative opioid consumption as a measure of efficacy in patients undergoing elective minimally invasive colon surgery in an ERAS setting. Postoperative pain scores and length of stay (LOS) will also be measured. The simplicity of the three methods is ranked as: 1) placebo, 2) L-TAP and 3) US-TAP.
Phase:
Phase 4
Details
Lead Sponsor:
Claus Anders Bertelsen, PhD, MD
Nordsjaellands Hospital
Treatments:
Ropivacaine